lilly drug cymbalta duloxetine aka yentreve approved fda treatment generalized anxiety disorder today good people gad good lilly academic cheerleaders house people gad sometimes medication really good job treating symptoms sometimes red flags science match marketing case took little digging find red flag read press release clinical trials average patients treated cymbalta generalized anxiety disorder experienced percent improvement anxiety symptoms compared percent took placebo measured hamilton anxiety scale ham i seen full text appears published study cymbalta gad i find two duloxetine studies medline press release claims three studies seems odd perhaps i dig little deeper case let move efficacy duloxetine study referenced press release guess similar study examining zoloft gad participants averaged ham start treatment using press release numbers cymbalta group comes average placebo group came average difference points ham noticeable could clinician tell difference someone measure i think cases yes probably small difference adverse events reporting press releases often journal reports joke i sure safety compound infamous traci johnson case suggests may risk suicidality cymbalta i would prefer see data making firm association course given general link ssris newer antidepressants increased suicidality initial instinct leery cymbalta regard good lilly great news lilly zyprexa debacle continues unfold lilly search good news appears arrived cymbalta according indianapolis star cymbalta sales hit billion gad indication rapid expansion depression market i guessing looking least billion drug bad drug evidence working better older mostly patent ssris academics house dr susan kornstein virginia commonwealth university i mentioned past relation highly positive statements lexapro back press release states approval physicians patients happy know another medication available treat debilitating condition yeah dancing streets ssris likely showing similar efficacy cymbalta psychotherapy showing pretty good great outcomes gad likely better long term meds needed expensive medication amazing pattern repeats show medication least bit better placebo short term independent academic give stamp approval talk important new addition prevent untold amounts grief suffering safety data often glossed benefits compared existing treatments discussed helps people outside sponsoring company